Lyme Disease Diagnostic Market Outlook 2026-2034: by Test Type (ELISA, Western Blot, PCR / NAAT, Lateral Flow Assay, ImmunoBlot, Multiplex Microarray & Others), Sample Type, Technology, End User

The Lyme Disease Diagnostic Market is estimated at US$730.1 billion in 2026 and is projected to grow at a CAGR of 4.5% to reach US$1.03 trillion by 2034.

Market Overview

The lyme disease diagnostic market covers laboratory assays, rapid tests, molecular methods, immunoassays, sample processing solutions, and related services used to detect infection associated with tick borne borrelia exposure. These diagnostics are used across hospitals, specialty laboratories, public health institutions, physician offices, and reference testing networks for early infection assessment, confirmatory testing, and differential diagnosis in patients with compatible symptoms or exposure history.

The value chain spans reagent developers, instrument manufacturers, assay providers, distributors, diagnostic laboratories, clinical care settings, and public health stakeholders involved in specimen collection, analysis, interpretation, and follow up care. Market relevance is also reinforced by seasonal testing demand, public health concern in endemic areas, and broader investment in infectious disease diagnostic capability.

Market Segmentation

By Test Type

• ELISA
• Western Blot
• PCR / NAAT
• Lateral Flow Assay (Rapid)
• ImmunoBlot
• Multiplex Microarray & Others

By Sample Type

• Blood / Serum
• Cerebrospinal Fluid
• Urine
• Skin Biopsy
• Synovial Fluid

By Technology

• Serologic (Antibody-based)
• Molecular
• Point-of-Care Platforms
• Multiplex Diagnostic Platforms
• Digital & AI-augmented Diagnostics

By End User

• Hospitals & Clinics
• Diagnostic Laboratories
• Research Institutes
• Homecare / Direct-to-Consumer

Key Companies Analysed

• Abbott Laboratories
• Roche Diagnostics
• Thermo Fisher Scientific
• Bio-Rad Laboratories
• Siemens Healthineers
• QIAGEN
• Danaher
• Ortho Clinical Diagnostics
• Trinity Biotech
• Zeus Scientific
• Gold Standard Diagnostics
• Oxford Immunotec
• Adaptive Biotechnologies
• Euroimmun
• BioMérieux
• Alere
• Hologic
• BD
• Meridian Bioscience
• DiaSorin

Geographic Coverage

• North America - Market data and outlook to 2034
  • United States
  • Canada
  • Mexico
  
  
• Europe - Market data and outlook to 2034
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Netherlands
  • Switzerland
  • Poland
  • Sweden
  • Russia
  
  
• Asia-Pacific - Market data and outlook to 2034
  • China
  • Japan
  • India
  • South Korea
  • Australia
  • Indonesia
  • Malaysia
  • Vietnam
  
  
• Middle East and Africa - Market data and outlook to 2034
  • Saudi Arabia
  • South Africa
  • Iran
  • UAE
  • Egypt
  
  
• South and Central America - Market data and outlook to 2034
  • Brazil
  • Argentina
  • Chile
  • Peru
  
  

*We can include data and analysis of additional countries on demand.

Report Delivery and Support

• Updated PDF report and an MS Excel workbook containing market tables and figures.
• 7-day post-sale analyst support for clarifications and in-scope supplementary data.
• Complimentary report update covering the latest available data and relevant market developments.

This product will be delivered within 1-3 business days.